Tapentadol prolonged release for patients with multiple myeloma suffering from moderate-to-severe cancer pain due to bone disease.

  • Home/
  • Tapentadol prolonged release for patients with multiple myeloma suffering from moderate-to-severe cancer pain due to bone disease.

Tapentadol prolonged release for patients with multiple myeloma suffering from moderate-to-severe cancer pain due to bone disease.

  • Post by:
  • February 18, 2020
  • Comments off
Categories:

Address

NEMA Research, Inc.
868 106th Ave North
Naples, FL  34108

Contact Information

Call: +1 (239) 597-3594

Social Links